Unknown

Dataset Information

DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.


ABSTRACT: Conducting vaccine efficacy trials during outbreaks of emerging pathogens poses particular challenges. The "Ebola ça suffit" trial in Guinea used a novel ring vaccination cluster randomized design to target populations at highest risk of infection. Another key feature of the trial was the use of a delayed vaccination arm as a comparator, in which clusters were randomized to immediate vaccination or vaccination 21 days later. This approach, chosen to improve ethical acceptability of the trial, complicates the statistical analysis as participants in the comparison arm are eventually protected by vaccine. Furthermore, for infectious diseases, we observe time of illness onset and not time of infection, and we may not know the time required for the vaccinee to develop a protective immune respon

SUBMITTER: Dean NE 

PROVIDER: S-EPMC5878056 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature